Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 21220190)

1.

Glioblastoma in children: a single-institution experience.

Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, Simpson JR, Limbrick DL, Park TS, Mansur DB.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1117-21. doi: 10.1016/j.ijrobp.2010.03.013. Epub 2011 Jan 8.

PMID:
21220190
2.

[Combined surgery and radiotherapy of glioblastoma multiforme--report of 73 cases].

Lei YH.

Zhonghua Zhong Liu Za Zhi. 1990 Nov;12(6):469-71. Chinese.

PMID:
1963841
3.

Long-term outcomes in children with glioblastoma.

Song KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG, Kim IH, Ahn HS, Park SH, Kim SK.

J Neurosurg Pediatr. 2010 Aug;6(2):145-9. doi: 10.3171/2010.5.PEDS09558.

PMID:
20672935
4.

Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.

Fazeny-Dörner B, Gyries A, Rössler K, Ungersböck K, Czech T, Budinsky A, Killer M, Dieckmann K, Piribauer M, Baumgartner G, Prayer D, Veitl M, Muhm M, Marosi C.

Wien Klin Wochenschr. 2003 Jun 24;115(11):389-97.

PMID:
12879737
5.

Therapy of glioblastoma multiforme: a cumulative experience of 10 years.

Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H.

Acta Neurochir (Wien). 1995;137(1-2):29-33.

PMID:
8748864
6.

Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience.

Caloglu M, Yurut-Caloglu V, Karagol H, Bayir-Angin G, Turan FN, Uzal C.

J BUON. 2009 Apr-Jun;14(2):211-8.

PMID:
19650168
7.

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, et al.

J Clin Oncol. 1995 Jan;13(1):112-23.

PMID:
7799011
8.

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.

Brandes AA, Rigon A, Zampieri P, Ermani M, Carollo C, Altavilla G, Turazzi S, Chierichetti F, Florentino MV.

Cancer. 1998 Jan 15;82(2):355-61.

PMID:
9445194
9.

Pre-radiation chemotherapy in glioma patients with poor prognostic factors.

Watne K, Nome O, Hager B, Hirschberg H.

J Neurooncol. 1992 Jul;13(3):261-4.

PMID:
1325542
10.

Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.

López-Aguilar E, Sepúlveda-Vildósola AC, Rivera-Márquez H, Cerecedo-Díaz F, Hernández-Contreras I, Ramón-García G, Diegopérez-Ramírez J, Santacruz-Castillo E.

Arch Med Res. 2000 Mar-Apr;31(2):186-90.

PMID:
10880725
11.

[Results of conventional radiotherapy in malignant gliomas:].

Shibamoto Y, Yamashita J, Takahashi M, Yamasaki T, Kikuchi H, Abe M.

Gan No Rinsho. 1989 Sep;35(11):1240-6. Japanese.

PMID:
2554004
12.

Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival.

Fujii O, Soejima T, Kuwatsuka Y, Harada A, Ota Y, Tsujino K, Sasaki M, Kudo H, Nishihara M, Taomoto K.

Jpn J Clin Oncol. 2010 Aug;40(8):726-31. doi: 10.1093/jjco/hyq051. Epub 2010 Apr 21.

13.

Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.

Odrazka K, Petera J, Kohlova T, Dolezel M, Vaculikova M, Zouhar M, Malek V, Hobza V, Latr I, Nemecek S, Sercl M, Ryska P, Blaha M, Cermakova E.

Strahlenther Onkol. 2003 Sep;179(9):615-9.

PMID:
14628127
14.

[Diagnostic and treatment delays do not modify the treatment outcome of patients with multiform glioblastoma].

Noël G, Quetin P, Heymann S, Karamanoukian D, Schott R.

Cancer Radiother. 2009 Jan;13(1):17-23. doi: 10.1016/j.canrad.2008.10.002. Epub 2008 Dec 16. French.

PMID:
19091619
15.

Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.

Birol Sarica F, Tufan K, Cekinmez M, Sen O, Cem Onal H, Mertsoylu H, Topkan E, Pehlivan B, Erdogan B, Nur Altinors M.

J Neurosurg Sci. 2010 Mar;54(1):7-19.

PMID:
20436394
16.

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.

Chang EL, Yi W, Allen PK, Levin VA, Sawaya RE, Maor MH.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):519-28.

PMID:
12738329
17.

Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.

Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, Weiss C, Rödel C.

Radiother Oncol. 2010 Dec;97(3):382-6. doi: 10.1016/j.radonc.2010.06.014. Epub 2010 Sep 17.

PMID:
20850883
18.

[Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].

Zhou WN, Chen ZP, You C, Mu YG, Sai K, Zhang JY, Zhang XH, Cheng JJ, Xu HC.

Ai Zheng. 2004 Nov;23(11 Suppl):1555-60. Chinese.

PMID:
15566679
19.

Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.

Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, González González D.

Strahlenther Onkol. 2001 Jun;177(6):283-90.

PMID:
11446316
20.

Radiation therapy for pilocytic astrocytomas of childhood.

Mansur DB, Rubin JB, Kidd EA, King AA, Hollander AS, Smyth MD, Limbrick DD, Park TS, Leonard JR.

Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):829-34. doi: 10.1016/j.ijrobp.2009.11.015. Epub 2010 Apr 24.

PMID:
20421157
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk